In a major legal and corporate move, Fortis Healthcare has finally secured the rights to its own name, purchasing the Fortis trademark for Rs 200 crore from its former promoters, the Singh brothers, through a court-sanctioned auction.

Fortis Healthcare has reclaimed its brand name from its former promoters, Malvinder and Shivinder Singh, who lost control of the company amid a high-profile legal battle. The trademark, which had been tangled in litigation with Japanese pharma giant Daiichi Sankyo, was finally auctioned off under the supervision of the Delhi High Court, marking the end of a long and controversial saga.

The Singh brothers, once at the helm of both Ranbaxy Laboratories and Fortis Healthcare, sold Ranbaxy to Daiichi Sankyo in 2008. However, Daiichi later accused them of hiding crucial information regarding regulatory violations, winning an arbitration case in Singapore that led to the attachment of the Singh brothers' assets, including the Fortis trademark.

With the acquisition now complete, Fortis Healthcare—currently owned by IHH Healthcare via Northern TK Venture—has secured its rightful identity, reinforcing its position as a dominant player in India’s healthcare sector. The company, which operates a network of 26 hospitals across the country, boasts a market capitalisation exceeding Rs 50,000 crore.

This Rs 200 crore transaction not only resolves a legal tangle but also signals a fresh chapter for Fortis Healthcare, allowing it to move forward without the baggage of its turbulent past while continuing to expand its world-class medical facilities across India.